Doctors Say ‘No’ to NMR? RTI Exposes abysmal state of National Medical Register

New Delhi: Even though eight months have passed since the National Medical Register (NMR) was launched, NMC has till now received only 10,411 applications for doctors’ registration on NMR, revealed the data obtained through a recent Right to Information (RTI) application.

Further, NMC’s response to the RTI application filed by Dr. KV Babu revealed that among these 10,411 applications, till date, 10,237 applications have not been approved, and these also include 139 applications where a query was raised. The Commission also informed that altogether 02 applications have been rejected so far.

Earlier this year, the Union Minister of State for Health Smt Anupriya Patel informed the Parliament that India has altogether 13,86,150 registered allopathic doctors. Therefore, less than 1% of the registered doctors have so far applied for their registration on NMR. On the other hand, 10237 out of 10411 applications- meaning 98.32% of applications for NMR registration have not been approved yet.

Commenting on this, Dr. KV Babu, a health activist from Kerala, who filed the RTI, told Medical Dialogues, “NMC should understand the implications of 98% non approval of the applications and just more than 10,000 applicants of over 13 lakhs Indian doctors have even applied for the registration in about 8 months time. More the number of applications are non-approved, less the number of new applications! The situation was brought to the attention of the NMC chairman in October 2024 itself. Instead of rectifying the mistake, NMC is continuing the ineffective method of NMR registration & this will be a disaster.”

NMR is a dynamic database and will be a central repository of all registered doctors, in which their authenticity is verified by Aadhaar IDs. All the MBBS doctors who are registered on Indian Medical Register (IMR) have to register again on the NMR, the NMC said in a public notice recently, and added that all medical colleges/institutions, state medical councils (SMCs) are inter-linked on the portal.

Launching the NMR portal on 23.08.2024, the Apex Medical Commission has asked the registered medical practitioners to enter their details on the portal. The portal was envisioned as a transformative initiative to centralize and streamline the registration of doctors across India.

However, after the commencement of the registration process, doctors started complaining about the problems that they faced while trying to register themselves on this new centralized portal.

Earlier, Dr. Babu had also raised the problems faced by the doctors in registering on NMR. He had previously explained how the doctors had to wait for a long period of time to get the NMR registration despite getting approval from the concerned State Medical Councils.

He had informed that his own NMR registration could not be processed at NMC as it was returned four times with irrelevant queries. These included objections regarding the names of his university and state medical council, as well as discrepancies between the name on his Aadhaar card and his degree certificate.

Raising the problems faced by the doctors to register on NMR, Dr. Babu had written to the NMC Chairperson as well and he had suggested the Commission to automatically enrol the doctors once the registration number and degree certificates were verified by the SMC.

Previous RTI applications filed by the doctor had revealed that till December 2024, the names of only 284 doctors were included in NMR. Later, the Commission informed that till January 14, 2025, only 8598 applications were filed by Registered Medical Practitioners for NMR enrolment. Among these 6.198 applications were not approved.

Also Read: Only 8,598 out of 13 Lakh Doctors Applied to Register in NMR- RTI Reveals Shocking Data

Powered by WPeMatico

NBE Releases DNB Post Diploma 2025 Counselling Schedule, check out seat matrix, guidelines

New Delhi- Through a recent notice, the National Board of Examinations in Medical Sciences (NBEMS) has released the schedule for the Online Centralised Merit-Based Counselling- DNB (Post Diploma) 2025 admission Session.

As per the schedule, the said counselling will commence from 8th and will end on 4th June, 2025.

Below is the complete schedule-

SCHEDULE

S.NO

COUNSELLING PROCESS

SCHEDULE

FIRST ROUND

SECOND ROUND

1

Registration for Counseling.

8th to 12th May, 2025 (till 05:00 PM).

No new Registration

2

Filling up options/ choices of available seats.

8th to 12th May, 2025 (till 05:00 PM)

23rd to 26th May, 2025 (till 05:00 PM)

3

Processing of Allotment.

13th May, 2025

27th May, 2025

4

Result of Allotment.

14th May, 2025

28th May, 2025

5

Payment of First Year Course Fee.

14th to 19th May, 2025 (till 05:00 PM)

28th May to 4th June, 2025 (till 05:00 PM)

6

Physical Joining at the allotted hospital.

14th to 19th May, 2025 (till 05:00 PM)

28th May to 4th June, 2025 (till 05:00 PM)

Registration & filling of choices has to be done through the official website of NBE. Therefore, following steps must be completed to participate in the counseling-

1 Payment of registration fee for online counseling.

2 Upload prescribed documents.

3 Choice filling.

4 Lock and Confirm the choices filled.

Meanwhile, it is to be noted that the allotment of seats in the Counseling is subject to the fulfilment of prescribed eligibility criteria and production of prescribed credential in original at the time of joining the institute allotted.

To view the notice, click the link below

https://medicaldialogues.in/pdf_upload/noticejpg-285254.pdf

In this regard, NBEMS has also released the Handbook for the Centralized Merit Based Counseling for Admission to Post Diploma DNB Courses 2025 Admission Session. The handbook contains important details such as eligibility, application process, documents, etc.

PROCEDURE FOR REGISTRATION WITH NBEMS FOR DNB POST DIPLOMA COURSES AFTER JOINING IN THE ALLOTTED INSTITUTE

1 Candidate who has Joined the allotted seat shall be referred as NBEMS trainee.

2 The candidates will upload the documents at NBEMS website and the hospital will also update the joining status at the same website.

3 NBEMS has a web portal called Online Portal for Joining and Registration (OPJR). Candidates as well as the concerned Hospitals/ Institutes are required to complete the Joining as well as Registration formalities after conclusion of all rounds of counseling. OPJR shall not be accessible for both candidates as well as institutes during the ongoing process of counseling.

4 Subsequent to conclusion of counseling, the candidate and hospital shall be able to access the Online Portal for Joining and Registration (OPJR) through web-link where they shall be required to complete the joining and registration formalities.

5 A detailed notice for Self-Appraisal shall be published after conclusion of Counseling for Joined candidates to register themselves as trainees with NBEMS. The joining of a candidate for a course is considered complete only after successful submission of Self-Appraisal to NBEMS both by the candidate and its training institution.

ELIGIBILITY CRITERIA FOR PARTICIPATION IN THE CENTRALIZED MERIT BASED COUNSELING FOR ADMISSION TO POST DIPLOMA DNB COURSES-2025 ADMISSION SESSION

1 Candidates must be in possession of Post Graduate Diploma Medical Qualification Pass Certificate/ Provisional# Pass Certificate in eligible feeder specialty for respective DNB (Post Diploma) course as mentioned in the Information Bulletin for DNB PDCET 2025.

2 Candidates must have qualified the Post Graduate Diploma Qualification in the eligible feeder specialty on or before 31st January, 2025.

3 The Post Graduate Diploma Medical Qualification in the eligible feeder specialty must be recognized as per the provisions of the NMC Act 2019 and the repealed Indian Medical Council Act 1956, Govt. of India.

4 Candidates should possess Permanent Registration Certificate of MBBS qualification.

5 Candidates must have appeared in DNB PDCET 2025.

6 Candidates already pursuing a Postgraduate course (MD/ MS/ DNB/ PG Diploma) are not eligible for admission to DNB (Post Diploma) courses for the entire duration prescribed for the course already joined by them earlier. This shall be irrespective of their resignation or discontinuation from the said course due to any reason.

7 Candidates who have qualified Post Graduate Diploma Medical Qualification after 31st January, 2025 are ineligible to participate in the counseling for admission to DNB (Post Diploma) – 2025 Admission Session. Any requests for admission to DNB (Post Diploma) – 2025 Admission Session from the candidates who have qualified Post Graduate Diploma after 31st January, 2025 shall be summarily rejected.

8 Candidates possessing Diploma qualifications awarded by the College of Physicians and Surgeons (CPS), Mumbai other than DPB, DCH and DGO are NOT eligible to join DNB (Post Diploma) Course.

9 In an event ineligibility is detected at any stage, NBEMS reserves its rights to cancel the result/candidature for DNB PDCET 2025 of such candidates for DNB PDCET 2025, even if the result has been declared or candidate has participated in the counseling or admitted to the DNB (Post Diploma) Course 2025 admission session.

10 Candidates who join DNB (Post Diploma) Course in 2025 admission session, after opting a confirmed seat through DNB Post Diploma Centralized Merit based Online Counseling 2025 session shall not be eligible to join any other DNB course for the entire duration of their DNB Post Diploma Course (i.e. 2 years). This shall be irrespective of their resignation or discontinuation from the course due to any reason.

11 Jurisdiction for disputes, if any, shall be at New Delhi only.

LIST OF PRESCRIBED DOCUMENTS TO BE UPLOADED AT THE TIME OF REGISTRATION IN THE 1ST ROUND OF COUNSELING

1 MBBS Degree certificate.

2 Post Graduate Diploma Medical Qualification Pass certificate/ Provisional Pass Certificate* in eligible feeder specialty for respective DNB (Post Diploma) course as mentioned in the Information Bulletin for DNB PDCET 2025.

3 Permanent Registration certificate issued by MCI/ State Medical Council for registration of MBBS qualification.

4 Proof of having passed the Post graduate diploma final examination on or before 31st January, 2025.

5 Screenshot of NMC website confirming that the Post Graduate Diploma Medical Qualification is recognized as per NMC Act, 2019 and the repealed Indian Medical Council Act 1956.

6 Matriculation/ High School/ Higher Secondary Certificate as a proof of Date of Birth.

7 SC/ST/PWD/OBC/EWS certificate issued by competent authority, if applicable. Caste certificate must be issued by competent authority. The sub caste should tally with the Central Govt. list.

8 Valid Government issued Identity proof with Photograph.

9 Any other relevant certificate or document such as NOC or relieving order etc.

To view the Handbook, click the link below

https://medicaldialogues.in/pdf_upload/handbookjpg-285259.pdf

SEAT MATRIX

Along with this, NBEMS has also released the Indicative Seat Matrix for admission to DNB Post Diploma courses for the 2025 Admission Session. As per the seat matrix, a total of 2197 seats are vacant across 14 DNB Post Diploma courses.

S.NO

SPECIALITY

TOTAL NO. OF SEATS

1

Anaesthesiology.

516

2

Dermatology, Venereology and Leprosy .

14

3

Family Medicine.

18

4

Nuclear Medicine.

14

5

Obstetrics and Gynaecology.

281

6

Orthopaedics.

378

7

Otorhinolaryngology (ENT).

57

8

Paediatrics.

280

9

Pathology.

74

10

Physical Medicine and Rehabilitation.

3

11

Psychiatry.

22

12

Radiation Oncology .

75

13

Radio Diagnosis.

272

14

Respiratory Medicine.

193

TOTAL

2197

To view the seat matrix, click the link below

Powered by WPeMatico

Fake Doctor Busted in Dimapur after years of fradulent practice

Dimapur: A fake medical practitioner from Dimapur, who had been fraudulently practising as a doctor for years without possessing any valid medical qualifications, has been arrested by the Nagaland Police.   

The man was detained following a formal complaint lodged by the Nagaland Medical Council. The council alleged that the fake doctor had been treating patients without the mandatory registration under the Medical Council Act 2014, Chapter III, Section 16(6).

Also Read: Fake orthopaedic surgeon arrested for using forged degrees, Fraudulent IDs

In a statement, the police said that the accused, a resident of NST Colony, was found to be posing as a doctor in the commercial hub of Dimapur, reports India Today NE.

Following the complaint, police conducted a preliminary inquiry, which confirmed that the accused neither held a recognized medical degree nor was registered with the State Medical Council — a legal requirement for anyone practising medicine in India. 

Also Read: Fake Cardiologist booked for culpable homicide in Chhattisgarh Ex-Speaker’s 2006 Death

As per the recent media reports by TOI, during the investigation, Lotha claimed to have obtained an MBBS degree from Rajiv Gandhi University of Health Sciences in Bengaluru in 2014. However, official records from the institution revealed that he had enrolled in 2008 but had failed to complete even one year of studies. Sophie said Lotha had befriended medical professionals and had been “smartly” operating under the guise of a qualified doctor.

Authorities have registered a case under relevant sections of the law related to impersonation and illegal medical practice. Investigations are underway to assess the full scope of the accused’s activities, including any medical treatments administered and potential harm caused to unsuspecting patients.

In light of the incident, the Dimapur Police have issued a public advisory, urging residents to exercise caution and verify the credentials of medical professionals before seeking treatment. They stressed the importance of checking whether a practitioner has a valid State Medical Council registration number.

According to the India Today NE, appealing to the public to report any suspicious individuals who may be practising medicine without proper documentation, the police said, “This is a collective responsibility to ensure a safe and trusted medical environment in our community.”

Powered by WPeMatico

AstraZeneca Breztri met primary endpoints in Phase III trials in asthma

AstraZeneca has announced the Positive high-level results from the Phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that fixed-dose triple-combination therapy Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate or BGF (320/28.8/9.6μg)) met all primary endpoints, demonstrating a statistically significant and clinically meaningful improvement in lung function compared with dual-combination inhaled corticosteroid/long-acting beta2-agonist (ICS/LABA) medicines.

KALOS and LOGOS were replicate, randomised, double-blind trials designed to investigate Breztri as a potential treatment for asthma. The trials evaluated the efficacy and safety of Breztri versus maintenance treatment with ICS/LABA in adults and adolescents with uncontrolled asthma.

Asthma is a common, chronic respiratory disease characterised by inflammation and muscle tightening in the airway (bronchoconstriction), which can make it difficult to breathe. As many as 262 million people worldwide are affected by asthma, and it is estimated that nearly half of those treated with dual therapy remain uncontrolled, which can significantly limit lung function and decrease quality of life.

Alberto Papi, Professor and Chair of Respiratory Medicine at the University of Ferrara, and Director of the Respiratory Unit, CardioRespiratory Department, S. Anna University Hospital, Ferrara, Italy, and primary investigator, said, “Despite advancements in asthma treatments, millions of patients remain uncontrolled, which can cause frequent breathlessness, coughing and wheezing, significantly impacting their ability to perform daily activities. The results from the KALOS and LOGOS trials are exciting and demonstrate the potential of budesonide/glycopyrronium/formoterol to evolve the standard of care to more effectively treat asthma in a single inhaled triple therapy for patients who remain uncontrolled with dual maintenance therapy.”

Sharon Barr, Executive Vice President, BioPharmaceuticals R&D, AstraZeneca, said, “We are excited by the positive results from the KALOS and LOGOS trials, which demonstrate that Breztri could help improve the lives of the millions of patients living with asthma. These asthma data build on the well-established profile of Breztri in COPD, and we look forward to sharing with regulatory authorities to bring this important medicine to a wider group of patients.”

There were no new safety or tolerability signals identified for Breztri in KALOS or LOGOS.

Full results from the two Phase III trials will be shared with regulatory authorities and presented at an upcoming medical meeting.

Breztri is an inhaled triple-combination therapy approved for the treatment of chronic obstructive pulmonary disease (COPD) in adults in more than 80 countries worldwide including the US, EU, China and Japan.

Powered by WPeMatico

Fast-Track Recruitment for vacant posts in Health Department: MP Health Minister

Bhopal: In a move to address the shortage of staff and improve workforce conditions in the healthcare sector, Madhya Pradesh Health Minister and Deputy Chief Minister Rajendra Shukla has instructed officials to fast-track the recruitment process for vacant posts in the Health Department. He also instructed them to prepare proposals for amending existing rules and simplifying procedures, if necessary, to ensure timely recruitment.

The directive was issued during a high-level meeting at the State Secretariat in Bhopal with senior officials from the Health Department, General Administration Department, and the Staff Selection Board.

During the meeting, the minister reviewed the status of current recruitment efforts and emphasized aligning actions with the state government’s broader priorities for public health. He also emphasized improving working conditions and ensuring greater recognition for healthcare workers, particularly those under the National Health Mission (NHM). One of the key points of the meeting was the recruitment of 1,200 Class IV Hospital Assistants. Officials were directed to finalize the examination format and syllabus for the recruitment drive and to ensure its timely implementation.

Also Read: Fake Doctor Case: Missionary Hospital’s cath lab sealed

According to The Statesman, Deputy Chief Minister Shukla emphasised that the contributions of health workers, who provide round-the-clock services, must be duly recognised. He instructed officials to take proposals aimed at improving their conditions seriously and to prepare such proposals in consultation with the Finance and General Administration Departments.

Further, the minister addressed longstanding concerns among healthcare workers regarding salary discrepancies and grade-pay inconsistencies. He urged departments to work collaboratively to resolve these issues and ensure that National Health Mission (NHM) employees receive benefits equal to those of regular government staff.

Medical Dialogues had earlier reported that Chief Minister Mohan Yadav inaugurated the Kabra Hospital and Research Centre in Badnagar, Ujjain district. During the inauguration, Yadav emphasized the supreme contribution of doctors to society, highlighting medical service as the best form of service to humanity. He encouraged all medical professionals to place kindness, compassion, and humanity at the forefront of their work, underlining the importance of these values in healthcare.

Also Read: Fake Cardiologist held, linked to Ex-Chhattisgarh Speaker’s death

Powered by WPeMatico

Ensuring Medical Facilities in Govt Hospitals Constitutional Obligation of State, Courts can intervene if neglected: HC

Chennai: The Madras High Court bench recently observed that the State Government was constitutionally obligated to ensure the availability of medical facilities in government hospitals and make such facilities available to the underprivileged citizens of the country.

Further, the HC bench comprising Justices MS Ramesh and AD Maria Clete noted that when the State would neglect such obligations, the Court had authority under Article 226 of the Constitution of India to issue positive directions for such provisions.

“On an overall appraisal of all the decisions of the Hon’ble Supreme Court, we have no difficulty in holding that the provision of a medical facility in the Government Hospitals, so as to reach the poor, downtrodden and underprivileged citizens of the society, is a constitutional obligation of the State and when such facilities are neglected by the State Government, this Court would be well within its powers under Article 226 of the Constitution of India to issue positive directions for such provisions,” observed the High Court bench.

These observations were made by the High Court bench while considering the public interest litigations regarding the absence of guidelines in respect of standards of medical and infrastructural facilities available in the Government Hospitals and for the establishment of Bone Marrow Transplantation facilities in government hospitals.

In their pleas, the petitioners informed the High Court that apart from the Rajiv Gandhi General Hospital, Chennai, the Institute of Child Health and Hospital for Children in Egmore, and the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), no other government hospitals in the State had facilities for free bone marrow transplant.

The petitioners further pointed out that the Bone Marrow Transplant procedure is used to treat rare medical conditions, and it involves a huge expenditure. They submitted that since the facilities were available only in Chennai, people from the southern districts of the State had to face hardship to avail of this facility.

Meanwhile, the Additional Advocate General relied on the status report filed by the Directorate of Medical Education which said that the total estimated cost for Civil Structure, Equipment, and Staff sanctioning would be Rs 13,52,76,000 and the Annual Expenditure for the medical and non-medical staff would be an additional sum of Rs 3,63,76,000. 

Further, the AAG informed that the equipment for blood bank, oncopathology, etc. would cost Rs 4,99,00,000. It was further submitted that the medical officers were also deputed from Dindigul and Madurai for a three-month training programme.

He also added that the Medical Officers in the rank of Professor from Government Medical College, Dindigul and two Associate Professors from Madurai Medical College have been deputed to undergo the Bone Marrow Training Programme at ICHHC, Chennai. However, the AAG submitted that the estimated cost for the proposal for Civil Structure, Equipment and Human Resource for establishment of BMT at Government Rajaji Hospital, Madurai is subject to the approval of the Government.

Apart from this, the AAG also informed the Court that the State was not in a position to give a probable time limit for such establishment of the facility, since it involves the policy decision of the Government.

After taking note of the submissions, the Court noted that even though the State report began with a positive note, the rider that the proposals as well as time-limit were the policy decision of the government was not appreciable.

The HC bench noted that there was no dispute regarding the fact that apart from RGGH and ICHHC at Chennai, no other Government Hospital, within the State of Tamil Nadu, had the facility to provide free BMT procedure. 

“In the status report dated 30.09.2024, the Government have set out a proposal submitted by the Dean, Government Rajaji Hospital, Madurai and have estimated the proposal for civil structure, equipments and human resource for establishment of BMT in Government Rajaji Hospital, Madurai at Rs. 13.53 crores. The facility of BMT requires to be extended to atleast one General Hospital in each district, by taking into account the unavailability of such a facility in any of the districts, except Chennai. The Government shall take into consideration all the imminent and crucial medical procedures, which have been deprived to the poor and underprivileged section of the public in the remotest districts and shall endeavour to extend the facilities at the earliest,” observed the Court.

It was observed by the HC bench that the Director of Medical Education had come out with a proposal with estimation for extending the BMT facility at the Government Rajaji Hospital, Madurai. Accordingly, the bench held that “Now that the Director of Medical Education has come out with a proposal with estimation for extending the BMT facility at the Government Rajaji Hospital, Madurai, the Principal Secretary, Health and Family Welfare Department, Government of Tamil Nadu, shall consider the proposal, extracted in their status report dated 30.09.2024 and allocate the necessary funds at the earliest, in any event, within a period of three months from the date of receipt of a copy of this order.”

Regarding the prayer for framing necessary guidelines in respect of the Standards of medical and infrastructural facilities in all the Government Hospitals, the Court noted that the High Court, through an interim order dated 17.06.2019, had constituted a three-member committee to conduct an inspection as to the availability of basic infrastructures and maintenance of the hospitals in a neat and tidy sanitary condition and also as to the availability of adequate manpower with the basic functions.

The Court observed that after the interim order, the committee had visited the Government Hospitals at Srivilliputhur, Ramanathapuram, and Paramakudi and through their report dated 22.07.2019, it proposed certain recommendations for improving these hospitals.

“However, several years have lapsed, since the inspection was conducted and it would not be conducive to act upon the suggestions and recommendations made by the Committee,” noted the Court.

Taking note of this, the bench granted liberty to the petitioner to make a representation to the authorities for framing of guidelines, touching upon the standards of medical and infrastructural facilities in the Government Hospitals with a consequential direction to the Government to consider the same, to secure the ends of justice.

Accordingly, the bench issued the following directions:

 (a) the respondents shall allocate the necessary funds for civil structure, equipments and human resource for establishment of BMT facility at Government Rajaji Hospital, Madurai, within a period of three months from the date of receipt of a copy of this order.

(b) on such allocation of funds, the respondents shall ensure that the facility of BMT is established at Government Rajaji Hospital, Madurai, within a period of six months from the date of allocation of the funds.

(c) the petitioners herein are granted liberty to make an appropriate representation to the respondents, seeking for framing of suitable guidelines, in respect of the standards of medical and infrastructural facilities in all the Government Hospitals in the State of Tamil Nadu and on receipt of the same, the Principal Secretary, Health and Family Welfare Department, Government of Tamil Nadu, shall consider it and pass suitable orders in accordance with law, within a period of three months from the date of receipt of such representation

To view the order, click on the link below:

https://medicaldialogues.in/pdf_upload/gurushankar-v-the-chief-secretary-597259-284579.pdf

Also Read: HC orders TN medical council to update records Over MD Upgrade Delay Due to Seat Dispute

Powered by WPeMatico

Release Revised Internship List: FMGs Urge Bihar Govt

Patna: The foreign medical graduates have urged the Bihar Health Department to urgently release the corrected list of the mandatory internship programme, which is mandatory for all the medical graduates from abroad.

Even though the Bihar Medical Council had released the internship lists, recently the State Health Department cancelled two such lists for the FMGs due to errors. 

Consequently, a notice was issued by the Deputy Secretary of the Bihar Government on 22.04.2025. In that said communication, the Deputy Secretary wrote to the Principal of all Government Medical Colleges regarding the cancellation of allotment of medical college hospitals allotted by Bihar Council of Medical Registration, Patna, for internship of FMG students.

Addressing the issue, the Government had mentioned how the FMGs were allotted internship opportunities at private and government medical colleges through various letters of the Registrar of Bihar Council of Medical Registration, Patna.

However, the letter mentioned how “This allotment of the Registrar, Bihar Council of Medical Registration, Patna is contrary to the provision mentioned in clause-03 of letter No. U-15024/9/2023-UGMEB, dated-07.12.2023 of National Medical Commission, New Delhi.”

Accordingly, it cancelled the internship allotment and informed that the process of FMG internship allocation would be done separately by the Department. “In view of the above, the allocation of medical colleges for Compulsory Rotating Medical Internship to FMG students by the Registrar, Bihar Council of Medical Registration, Patna is cancelled with immediate effect. The process of allocation of medical colleges to FMG students under Compulsory Rotating Medical Internship will be done separately by the department,” the communication dated 22.04.2025 had mentioned.

However, more than a week has passed since the State cancelled the FMG internship allotments and no revised internship list has been released yet. Highlighting this, the All FMGs Association recently urged the Bihar Health Department to immediately released the revised list. The association pointed out how the delay in internship allotment was affecting the career of several aspiring doctors, who need to complete their mandatory internship training to be able to register themselves as doctors in India and practice.

Also Read: ESIC Patna FMG interns awaiting Stipend for 8 Months seek govt intervention

Powered by WPeMatico

Not a Nice Time For Dr Reddy’s? DTAB, CDSCO Recommend Stringent Restrictions on Nimesulide

New Delhi: Nimesulide, a widely used painkiller in India, is facing renewed regulatory scrutiny over its safety profile, with India’s apex drug advisory committee, recommending that the drug not be used as a first-line treatment and that high-dose oral formulations above 100 mg be prohibited.

However, Dr Reddy’s Laboratories, one of the largest marketers of the drug under the brand name ‘Nise’, has defended its safety and efficacy, asserting that the drug is supported by years of clinical research and that it does not sell formulations exceeding 100 mg. The company has also submitted detailed representations to regulatory authorities and expert panels to prevent a blanket ban.

During a recent meeting, the DTAB examined an Indian Council of Medical Research (ICMR) report on the drug’s effects in adults and recommended several restrictions. While acknowledging that Nimesulide remains effective for short-term fever relief, the board advised that it should only be used as a second-line treatment, after exhausting first-line options.

The DTAB also supported ICMR’s recommendations to prohibit oral formulations of Nimesulide above 100 mg in immediate release form and advised against its use in pregnant or lactating women, those planning pregnancy, and patients with liver or kidney impairment. It also recommended avoiding co-administration with other hepatotoxic or nephrotoxic drugs. Further, the committee has asked ICMR to conduct a systematic review of the drug’s use in vulnerable age groups—including children below 12, adolescents between 12 and 18, and seniors above 60—for future deliberation.

Nimesulide, a non-steroidal anti-inflammatory drug (NSAID), was launched in Italy in 1985 but has never been approved in the US, UK, Canada, Australia, Japan, or New Zealand due to safety concerns. Approved in India in 1995 for treating pain, inflammation, and fever, it became popular for its rapid onset of action. It is marketed under various brand names in India, including Nise, Nimrest, Nimopen, Nicip, and others, in 100- or 200-mg dosage strengths.

Also Read: Revise Phase IV Clinical Trial Protocol Of Nimesulide Granules For Oral Suspension: CDSCO Panel Tells Dr Reddys

Last year, amid concerns over its potential to cause liver damage, the Union Health Ministry asked the ICMR to assess its safety in adults. The ICMR had earlier considered recommending a nationwide ban but was instead directed by the DTAB to conduct a detailed review in specific populations.

In its report, the ICMR proposed banning all formulations above 100 mg and suggested adding a “black box” warning on all products containing the drug.

According to a News18 report, an 11-page ICMR report called upon nimesulide’s poor safety profile and recommended that it be reserved only as a second-line treatment.

Dr Reddy’s Defends Nimesulide Amid Safety Concerns

Despite these concerns, Hyderabad-based pharmaceutical company Dr Reddy’s Laboratories—India’s largest seller of branded nimesulide—has strongly defended the drug.

In a statement to News18, the company said, “Robust research and clinical trials have consistently established the safety and efficacy of Nimesulide, when used as prescribed.” It also stated that it does not market doses above 100 mg and clarified its prescribing guidelines: “Nimesulide is not recommended for use in pregnant or lactating women and patients with renal or hepatic impairments.”

In a letter submitted to the Drug Controller General of India, ICMR, and Directorate General of Health Services, the company argued against banning the drug, citing multiple court rulings and past DTAB evaluations affirming its safety.

“We wish to highlight that the subject matter of the safety of Nimesulide came before various courts such as the High Court of Judicature at Delhi and Madras in 2004, and again in 2008, and most recently before the Delhi High Court in 2023,” the letter stated.

Dr Reddy’s noted that “no causal relationship with serious liver toxicity or Reye’s Syndrome… was reported by any of these experts” and that “DTAB and other independent bodies have consistently found no significant adverse effects.”

The company reiterated that the drug remains safe when used appropriately and submitted additional safety data from Indian and international sources, including the WHO, to support its claim.

“We submit that the data enclosed clearly establish Nimesulide’s safety as one of the highest in its category,” stated Sandeep Khandelwal, Head – India Sub-Continent, Dr Reddy’s Laboratories.

According to market data from Pharmarack, Dr Reddy’s ‘Nise’ brand generated a moving annual turnover (MAT) of Rs 94 crore as of March 2025, followed by Mankind Pharma, Maneesh Pharmaceuticals, and IPCA Labs.

The International Society of Drug Bulletins (ISDB), supported by the World Health Organization, had in 2008 called for a global withdrawal of nimesulide. “It offers no therapeutic advantage or better gastrointestinal safety compared with other NSAIDs, whereas it exposes patients to a higher risk of fatal hepatic disorders,” the ISDB had noted.

In response to these concerns, India banned nimesulide for children under 12 in 2011. More recently, the Union Health Ministry, following advisory board recommendations, banned its veterinary use in January 2025 to protect the vulture population.

Also Read: Have taken opinion for all formulation of drug Nimesulide for vulture conservation: Health Ministry to Delhi HC

Globally, the European Medicines Agency restricted nimesulide’s use to adults in 2002, and many countries, including the UK, US, Canada, Australia, Singapore, and Japan, have either banned or severely restricted it. Today, India and Pakistan remain among the few countries where it is still widely available for adult use.

Powered by WPeMatico

7 Years of Commission Service, Rs 69 Lakh Penalty: AFMC Pune Bond policy for MBBS 2025

Pune: MBBS aspirants getting admitted to the Armed Forces Medical College (AFMC), Pune, this year will have to compulsorily serve as Medical Officers in the Armed Forces Medical Services (AFMS) for seven years after completing their course.

At the time of getting admitted to the MBBS course at AFMC, the candidates will have to sign a bond agreement of Rs 69 lakh and if the candidates withdraw from the college after 7 days of admission, or if they fail to fulfill their bond service liabilities, they will have to pay the bond money as a penalty. 

Since last year, the bond amount set by AFMC has increased by Rs 2 lakh. Medical Dialogues had earlier reported that while last year, the MBBS aspirants were required to pay a bond fee of Rs 67 lakh, the year before that the amount was Rs 65 lakh.

“Candidates admitted to AFMC for MBBS course have a compulsory liability to serve as Commissioned Officers in the Armed Forces Medical Services. The offer of the type of commission will depend upon the vacancies available and shall be determined on merit-cum-option at the final MBBS examination. The liability of the SSC officers passing out of AFMC to serve in the Armed Forces Medical Services (AFMS) would be 7 (seven) years. The Permanent Commission (PC) Officers will have to serve in AFMS till date of superannuation. Complete details of Service Liability & Bond Agreement will be given to the candidates shortlisted for the screening,” stated the AFMC Information Brochure for Admission to MBBS Course 2025.

“At the time of admission, parents/guardians of the candidates are required to sign a bond agreement for Rs 69,00,000/- (Rupees Sixty-Nine Lakhs only). Any candidate withdrawing from the college after 7 days of admission [after 1600hrs (4PM)] will have to pay Bond Money as per existing rules,” the Brochure mentioned.

Removal from Service Liability: 

The Information Brochure for MBBS admission 2025 stated that any medical cadet declared Non-Service Liability (NSL) due to medical grounds where he/she contracted the disease/disability in the circumstances over which he/she has no control and for which he/she has not refused treatment will not be liable to pay the Bond money but will have to pay the cost of training, tuition fees and other charges as applicable for further period of study from the date they are declared NSL. NOC to undergo internship will be issued only after clearing all dues.

“Such NSL cadets will be permitted to avail hostel facility at the discretion of DGAFMS,” it stated.

According to the Brochure, the current current cost of training is Rs 28,166/- per week and it may be revised in future based on training cost approved by the Govt of India.

“In case of medical cadets removed / opted out from service liability after passing final MBBS examination, the NOC for joining internship training will only be issued after the Bond Money is paid in full. 20. Medical cadets who have been removed/opted out from service liability after passing final MBBS examination, will be permitted to join internship training in any of the approved AFMS Internship Hospitals,” it added.

As per the Brochure, altogether 150 candidates (including 5 Government Sponsored candidates from Friendly Foreign Countries) will be selected in the year 2025. Among these 145 candidates 115 boys and 30 girls) will be selected as Medical Cadets for undergoing MBBS at the Armed Forces Medical College, Pune with liability to serve in the Armed Forces Medical Services as Medical Officers. The candidates selected in addition to becoming doctors will also be commissioned as officers of the Indian Armed Forces, wherein they have to be both physically and psychologically robust to be able to undergo the rigors of life in the Armed Forces.

The selected candidates need to have leadership qualities, effective communication skills and exacting physical standards, as the same are prime requisites for serving officers of the Armed Forces, stated the Brochure.

Also Read: 7 years of Commission Service, Rs 67 lakh bond penalty: AFMS Bond policy for MBBS candidates 2024

Powered by WPeMatico

SC backs direction to prescribe only generic medicines, suggests countrywide adoption

While hearing a Public Interest Litigation that sought enforcement of a statutory code to regulate unethical marketing practices by pharma companies, the Supreme Court has recently observed that doctors across India should be directed to mandatorily prescribe only generic medicines to patients, instead of the brand names of medicines.

The top court bench orally remarked that if there was a statutory mandate for doctors to prescribe generic medicines, the issue of pharmaceutical companies allegedly bribing doctors to prescribe excessive or irrational drugs and push for high-cost, overpriced brands would be resolved, Live Law has reported.

For more information, click on the link below:

Powered by WPeMatico